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Some 50 experts participated in a technical meeting on envi-
ronmental enteric dysfunction organized and hosted by the In-
ternational Atomic Energy Agency (IAEA) in Vienna, Austria on 
October 28–30, 2015. The meeting aimed to discuss current re-
search, developments and experiences in diagnosing and evalu-
ating EED, and the potential role of stable isotope techniques in 
EED diagnosis. 
What is known about EED
Stunting develops as a result of sustained inadequate nutrition 
and recurrent infection.2 Environmental insults affect linear 
growth through mechanisms that are yet to be fully understood.3 
Environmental enteropathy is a combination of infection-under-
nutrition induced failure of the mucosal barrier of the gut and 
has recently been referred to as environmental enteric dysfunc-
tion to reflect the numerous gut function deficits associated 
with it. EED affects approximately 50–95% of children under 
the age of 5 years in resource-poor settings. There is compelling 
evidence to support the association of EED with: 1) gut perme-
ability/leakiness; 2) nutrient malabsorption; 3) microbial trans-
location; 4) alterations in gut microbiota diversity; 5) gut and 
systemic inflammation; 6) linear growth faltering; 7) reduced 
effect of vaccines and; 8) severe acute malnutrition (SAM).4
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 Key messages
 
 >  Stunting affects 161 million children under 5 years of age  
in low- and middle-income countries.1 
 
 >  Evidence-based nutrition interventions, at 90% coverage, 
amount to only one-third reduction in stunting. 
 
 >  Environmental insults acting through damaged gut  
function (a phenomenon referred to as environmental  
enteric dysfunction [EED]), are hypothesized to be  
responsible for a large part of intrauterine growth restriction  
and postnatal stunting, but the mechanisms remain  
largely unknown.
 
 >  Combating EED and stunting needs an integrated  
approach to improve the following: maternal health and  
pre-conception nutrition, infant and young child feeding 
(IYCF) practices, access to health care, and access to  
safe water and sanitation.
 
 >  A tool to assess EED is urgently needed to facilitate  
evaluation of interventions.
 >  Application of cutting-edge innovations such as the  
omics technologies and stable isotope techniques offer  
unprecedented opportunities to diagnose and  
characterize EED.
  
 >  Since EED depicts multiple causal pathways,  
striking the right mix of evidence-based interventions is a 
key prerequisite for success. Synergies across disciplines  
and sectors are needed.
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motility5 and is in turn influenced by factors including mode of 
delivery, breastfeeding practices, dietary diversity, genotype, 
pathobiology, physiology, age, the environment, immune system 
and host lifestyle.6 
 Unfavorable nutritional conditions can influence the micro-
bial community composition, most often resulting in sub-optimal 
microbiota maturity, which is in turn correlated with host weight 
loss. Although there are no studies to date of the gut microbiome 
in the specific context of EED, there is evidence that some gut 
intestinal pathogens have specific mechanisms of action (such 
as mucin degradation) that make a link with EED biologically 
plausible.7  
2. How does EED limit growth?
Insulin growth factor (IGF-I) regulates growth and other func-
tions in the body during pregnancy. Inflammation of the small in-
testine in EED is associated with high C-reactive protein and may 
be accompanied by release of cytokines such as interleukin  6 
(IL-6) that reduce appetite and food intake and impair produc-
tion and action of chondrocyte growth factors. Stress-induced 
activation of the hypothalamic-pituitary-adrenal axis stimulates 
a rise in cortisol and insulin-like growth-factor-binding protein-1 
(IGFBP-1), which inhibit IGF-1 action and induce chondrocyte 
apoptosis. A reduction in hepatic growth hormone (GH) receptor 
expression and inhibition of GH signaling by fibroblast growth 
1. Gut microbiome and EED
The gut microbiota is largely acquired at birth and develops 
quickly in the first year of life toward an adult-like pattern. It 
influences host development, immunity, metabolism and gut 
Participants of the technical meeting come from diverse  
professional fields 
Cornelia Loechl, Head of the Nutritional and Health-Related Environmental Studies Section, welcomes participants,  
gives an overview of IAEA’s activities in nutrition, and outlines meeting objectives.
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factor 21 and possibly zinc deficiency, further limit IGF-1 produc-
tion and thereby contribute to growth failure.8,9 
3. Energy and nutrient requirements in EED
Nutrient deprivation is associated with a decrease in epithelial 
barrier function and elevated detection of indicators for bacte-
rial translocation. Vitamin A, zinc and some amino acids such 
as glutamine, threonine, leucine and cysteine are potentially 
involved in improving gut barrier function and absorptive ca-
pacity. Zinc, probiotics, flavonoids and n-3 polyunsaturated 
fatty acids (PUFA) have been associated with reduced inflam-
mation.4 In contrast, inorganic iron potentially shifts the mi-
crobiome towards a more pathogenic profile and increases gut 
inflammation. Inflammation and reduced absorption, both of 
which are evident in EED, may result in increased energy and 
nutrient requirements in children with EED. In children with 
EED, energy and zinc requirements are increased by up to 15% 
and 50%, respectively. 
4. Use of stable isotopes in evaluating gut dysfunction
Stable isotopes have been used to assess gut dysfunction 
(small intestine bacteria overgrowth [SIBO], celiac disease and 
chemotherapy-induced small-intestinal damage in rats) with 
different substrates (starch and other carbohydrates, mixed tri-
glycerides, fatty acids, proteins, etc.). An example of a diagnos-
tic 13C breath test is the 13C-urea breath test used to diagnose 
and monitor Helicobacter pylori infection in the stomach. The 
high specificity and sensitivity associated with the test makes it 
the ideal non-invasive diagnostic technique.10 The 13C-sucrose 
breath test is a promising future technique to assess gut function 
and has been used in Australia to measure the absorptive capac-
ity of the small intestine.11 The glucose hydrogen breath test is 
currently the most accurate non-invasive test to diagnose SIBO. 
Combined 13C and H2 breath tests could also be used to assess 
fermentation and SIBO with higher specificity by correcting for 
gastric emptying rate. 
5. Biomarkers of EED
While malabsorption, gut barrier dysfunction and gut inflamma-
tion are overlapping components of EED, it is difficult to iden-
tify specific markers of each that could be used solely for EED 
diagnosis. An ideal EED biomarker should be highly associated 
with stunting, age- and population-specific, and classified ac-
cording to the underlying causes of EED, namely: 1) intestinal 
permeability and nutrient absorption (e.g., 13C sucrose breath 
test, lactulose-mannitol intestinal permeability test), 2) bacte-
rial translocation (e.g., lipopolysaccharides), 3) intestinal in-
flammation (e.g., myeloperoxidase), 4) systemic inflammation 
(e.g., C-reactive protein), 5) functional enterocyte mass (e.g., 
citrulline), 6) intestinal repair (e.g., promoter glucagon-like 
Panelists from different sectors deliberate how interventions can best be packaged to address EED and stunting.
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peptide-2 [GLP-2]), 7) mucosal immune underachievement 
(e.g., kynurenine/tryptophan ratio)12 and 8) alterations in mi-
crobiota diversity.
6. Ongoing interventions to address EED
Interventions to address EED include: a) water, sanitation and 
hygiene (WASH), b) reduction of exposure to feces and contact 
with domestic animals; c) provision of probiotics and prebiot-
ics; d) improvement of dietary diversity and breastfeeding prac-
tices; e) supplementation with nutrients such as zinc, PUFA and 
amino acids and; f) treatment with anti-inflammatory agents 
and antibiotics in the context of SAM and infection. Some of 
these aspects are already being tested individually or combined 
in large randomized controlled studies in a number of countries. 
Determining the right mix of evidence-based interventions to 
maximize effectiveness against EED remains a major gap.
7. The way forward
Several gaps in knowledge requiring attention include the clas-
sification and better understanding of the underlying causes of 
EED. Developing practical, simple, and affordable tools to diag-
nose and characterize EED to allow better targeting of interven-
tions in vulnerable populations is overdue. Stable isotopes can 
be used to assess absorptive capacity/permeability of the gut, 
bacterial translocation and body composition as a proxy indica-
tor of dietary quality and morbidity. Since EED depicts multi-
ple causal pathways, striking the right mix of evidence-based 
interventions is a key prerequisite for success. Synergies across 
disciplines and sectors are needed.
“ There is a need to develop tools  
to diagnose and characterize EED  
in order to allow better targeting  
of interventions in vulnerable  
populations”
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